India Healthcare Sector Booms: FY26 Growth & Capacity Expansion
By Business Desk
India’s healthcare sector experienced robust FY26 growth, driven by revenue expansion, capacity additions, and strong investor interest, particularly in Q4. Learn more.
India’s healthcare sector reported robust growth for fiscal year 2026, with a particularly strong performance in the fourth quarter, according to the **EY-Parthenon Report**. This significant expansion was primarily fueled by rising revenue across hospital networks and diagnostics, alongside continuous capacity additions and substantial investor engagement.
Underlying Growth Drivers
The sector’s impressive trajectory was propelled by several critical factors. Higher patient volumes, improved revenue realization per patient, and a strategic shift towards complex, high-acuity medical treatments all contributed to the overall positive momentum.
- Major hospital chains recorded over 15% year-on-year growth in both revenue and EBITDA.
- Occupancy rates for these chains were maintained between 60% and 75%.
- High-acuity specialties, including cardiology and oncology, expanded by more than 15%.
- Organized diagnostics providers saw over 15% year-on-year revenue growth, achieving EBITDA margins above 25%.
- Single-specialty hospitals also posted over 15% revenue growth and approximately 30% EBITDA margins.
Investment Dynamics and Challenges
Investment in the healthcare sector remained strong, with private equity interest notably driving an upward trend in valuations. However, the fourth quarter did observe a slight dip in overall transaction volumes.
Conversely, medical device manufacturers encountered significant headwinds. These challenges stemmed from US tariffs, elevated raw material costs, persistent logistics issues, and acquisition-related expenses, impacting their operational performance.
Future Outlook and Sustained Momentum
Looking ahead, the **EY-Parthenon Report** anticipates sustained growth for the Indian healthcare sector into fiscal year 2027. This continued expansion is expected to be underpinned by the increasing prevalence of chronic diseases, a heightened public health awareness, ongoing network expansions, and active mergers and acquisitions.